The development of an optimized 18F-FDG PET/CT radiomics model, predicting EGFR mutation status and prognosis in lung adenocarcinoma, was realized through a multicenter study (Arshad et al., 2019). The gene discussed is EGFR; the disease is lung adenocarcinoma.